BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	10,298	11,428	12,539	18,185	19,275	16,249
Market Cap Growth	-14.69%	-8.86%	-31.05%	-5.66%	18.63%	1.96%
Enterprise Value	9,567	10,465	11,996	18,198	19,067	16,314
Last Close Price	53.29	59.43	65.73	96.42	103.49	88.35
PE Ratio	38.20	33.02	29.74	110.83	137.99	-252.43
Forward PE	9.53	12.37	17.86	38.98	39.00	85.79
PEG Ratio	0.33	0.65	0.72	1.07	0.86	2.66
PS Ratio	3.19	3.55	4.39	7.52	9.20	8.80
PB Ratio	1.67	1.88	2.22	3.67	4.19	3.81
P/TBV Ratio	1.67	1.93	2.29	3.73	4.25	3.79
P/FCF Ratio	13.49	15.76	25.72	290.64	350.82	77.76
P/OCF Ratio	11.84	13.80	21.89	114.18	109.58	53.36
EV/Sales Ratio	2.95	3.25	4.20	7.52	9.10	8.84
EV/EBITDA Ratio	15.15	21.40	20.66	62.72	72.51	634.83
EV/EBIT Ratio	16.94	25.56	24.77	97.96	118.45	-198.13
EV/FCF Ratio	12.47	14.44	24.61	290.85	347.03	78.07
Debt / Equity Ratio	0.23	0.10	0.11	0.22	0.24	0.25
Debt / EBITDA Ratio	3.68	1.22	1.02	3.75	4.12	41.99
Debt / FCF Ratio	1.87	0.82	1.22	17.37	19.71	5.16
Net Debt / Equity Ratio	-0.13	-0.16	-0.10	0.00	-0.04	0.02
Net Debt / EBITDA Ratio	-2.04	-1.97	-0.93	0.05	-0.79	2.54
Net Debt / FCF Ratio	-1.03	-1.33	-1.11	0.21	-3.79	0.31
Asset Turnover	0.40	0.44	0.41	0.37	0.34	0.31
Inventory Turnover	0.59	0.57	0.50	0.53	0.60	0.64
Quick Ratio	3.94	3.25	2.96	1.45	2.98	2.54
Current Ratio	5.81	5.21	5.33	2.51	4.67	4.16
Return on Equity (ROE)	4.37%	5.94%	8.05%	3.51%	3.19%	-1.53%
Return on Assets (ROA)	2.71%	4.06%	5.52%	2.50%	2.46%	-1.18%
Return on Invested Capital (ROIC)	4.05%	5.63%	7.39%	3.44%	3.38%	-1.59%
Return on Capital Employed (ROCE)	4.31%	6.20%	8.04%	3.24%	2.86%	-1.52%
Earnings Yield	2.60%	3.03%	3.36%	0.90%	0.72%	-0.40%
FCF Yield	7.41%	6.34%	3.89%	0.34%	0.29%	1.29%
Buyback Yield / Dilution	-0.86%	-0.35%	-2.67%	-1.39%	-3.34%	4.60%
Total Shareholder Return	-0.86%	-0.35%	-2.67%	-1.39%	-3.34%	4.60%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q